CDD is excited to announce the opening of its BioHarmony Beta Program. BioHarmony is a centralized drug data store, providing semantic data on preclinical, clinical, and postapproval developments. Check out the debut of the BioHarmony Drug Data Store from our latest webinar below.
We are now accepting a limited number of enthusiastic applicants into our Beta Program. Beta testers will receive access to our entire BioHarmony Drug Data Store at a substantial discount while providing feedback to guide our product roadmap. If you are interested, please fill out the form below or contact us directly at support@biometadata.com.
Other posts you might be interested in
View All Posts
CDD Blog
19 min
June 6, 2025
Synthetic Lethality in Precision Oncology: Integrating AI-Driven Discovery with Data Management Platforms
Read More
CDD Blog
29 min
June 4, 2025
How to Choose the Right ELN or LIMS for Early-Stage Drug Discovery
Read More
CDD Blog
10 min
June 3, 2025
Chemical Registration in Drug Discovery
Read More